EV/EBITDA
1.24
-0.06-4.62%
Thu, 13 Mar 2025 13:45:43 GMT
Summary
- As of March 14, 2025, EGRX EV/EBITDA is 1.24, with a fall of -0.06 (-4.62%) during the most recent trading day.
- Over the past year, EGRX EV/EBITDA has dropped by -1.16 (-48.33%).
- EGRX EV/EBITDA is now -99.85% below its all-time high of 823.78.
Performance
EGRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
EGRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -4.6% | -4.8% | -20.8% |
| 1 m1 month | -2.4% | -2.7% | -12.7% |
| 3 m3 months | +6.0% | +5.5% | +37.3% |
| 6 m6 months | -37.7% | -38.0% | -76.1% |
| ytdytd | +10.7% | +11.0% | +106.0% |
| 1 y1 year | -48.3% | -48.4% | -83.0% |
| 5 y5 years | -92.6% | -85.2% | -97.4% |
EGRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.2% | 1.20 | +3.3% | |
| 3 m | 3-month | 1.35 | -8.2% | 1.09 | +13.8% |
| 6 m | 6-month | 2.06 | -39.8% | 1.08 | +14.8% |
| 1 y | 1-year | 2.41 | -48.5% | 1.08 | +14.8% |
| 3 y | 3-year | 683.40 | -99.8% | 1.08 | +14.8% |
| 5 y | 5-year | 710.84 | -99.8% | 1.08 | +14.8% |
| alltime | all time | 823.78 | -99.8% | -404.85 | +100.3% |
Eagle Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 1.24(+10.7%) |
| 2024 | 1.12(-49.5%) |
| 2023 | 2.22(-55.6%) |
| 2022 | 5.00(-99.3%) |
| 2021 | 685.47(+3559.7%) |
| 2020 | 18.73(-29.7%) |
| Date | Value |
|---|---|
| 2019 | 26.64(+104.8%) |
| 2018 | 13.01(+39.4%) |
| 2017 | 9.33(-55.8%) |
| 2016 | 21.13(-95.6%) |
| 2015 | 484.58(-6067.7%) |
| 2014 | -8.12 |
FAQ
- What is Eagle Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Eagle Pharmaceuticals?
- What is EGRX EV/EBITDA year-to-date change?
- What is Eagle Pharmaceuticals EV/EBITDA year-on-year change?
What is Eagle Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of EGRX is 1.24
What is the all time high EV/EBITDA for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high EV/EBITDA is 823.78
What is EGRX EV/EBITDA year-to-date change?
Eagle Pharmaceuticals EV/EBITDA has changed by +0.12 (+10.71%) since the beginning of the year
What is Eagle Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, EGRX EV/EBITDA has changed by -1.16 (-48.33%)